Clinical Trials Directory

Trials / Completed

CompletedNCT03764592

VF Mapping in Brugada and Early Repolarization Syndromes

Mapping of Ventricular Fibrillation (VF) Substrates and VF Arrhythmogenic Sources/Reentrant Circuits in Patients With Brugada and Early Repolarization Syndromes

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Pacific Rim Electrophysiology Research Institute · Academic / Other
Sex
All
Age
16 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To determine the values and limitations of ECGI in guiding ablation and risk stratification in patients with BrS and Early Repolarization.

Detailed description

The investigators will study symptomatic BrS and ERs syndrome (N=25) and asymptomatic patients (N=25) age between 16-70 years old to determine values and limitations of non-invasive mapping using electrocardiographic imaging (ECGI) in identifying VF substrates as target sites for catheter ablations in patients with Brugada (BrS) and Early repolarization syndromes (ERS) and also determine the mechanisms of VF in BrS and ERs syndromes.

Conditions

Interventions

TypeNameDescription
OTHERradiofrequency ablationSymptomatic patients whose substrates were identified will undergo catheter ablation; asymptomatic patients will be followed without undergoing catheter ablation.

Timeline

Start date
2018-02-23
Primary completion
2024-09-01
Completion
2024-09-01
First posted
2018-12-05
Last updated
2024-11-22

Locations

2 sites across 1 country: Thailand

Source: ClinicalTrials.gov record NCT03764592. Inclusion in this directory is not an endorsement.